GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Albert Labs International Corp (XCNQ:ABRT) » Definitions » Short-Term Debt

Albert Labs International (XCNQ:ABRT) Short-Term Debt : C$0.00 Mil (As of Sep. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Albert Labs International Short-Term Debt?

Albert Labs International's Short-Term Debt for the quarter that ended in Sep. 2023 was C$0.00 Mil.

Albert Labs International Short-Term Debt Historical Data

The historical data trend for Albert Labs International's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albert Labs International Short-Term Debt Chart

Albert Labs International Annual Data
Trend Dec21 Dec22
Short-Term Debt
- -

Albert Labs International Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Albert Labs International Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Albert Labs International Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Albert Labs International's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Albert Labs International (XCNQ:ABRT) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Albert Labs International Corp (XCNQ:ABRT) » Definitions » Short-Term Debt
Comparable Companies
XCNQ:MYND XCNQ:ENBI TSXV:IBO XCNQ:HAVN XCNQ:GTTX XCNQ:MOOD XCNQ:WESA.X TSXV:BTI XCNQ:AGN XCNQ:CURE OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
6996, Merritt Avenue, Burnaby, BC, CAN, V5J 4R6
Website
https://www.albertlabs.com
Albert Labs International Corp is a laboratory-based, clinical research and drug development enterprise addressing mental health care needs. The company is focusing on Real World Evidence (RWE) the company will initially look to commercialize its mycelium-based KRN-101 medicine and treatment with the help of clinical pathway.

Albert Labs International (XCNQ:ABRT) Headlines

No Headlines